Competition Commission of India (CCI) orders detailed probe against pharma major Roche Ruby Khatun Khatun26 April 2017 11:25 AM ISTNEW DELHI: The Competition Commission of India has ordered a detailed investigation against pharma major Roche and its two group firms for alleged...
Zydus Cadila gets USFDA nod for anti-hypertensive tablets Ruby Khatun Khatun26 April 2017 10:46 AM ISTNew Delhi, Apr 25: Drug firm Cadila Healthcare today said Zydus Cadila has received approval from the US health regulator to market its...
3 African countries chosen to test 1st malaria vaccine Ruby Khatun Khatun26 April 2017 10:21 AM ISTJOHANNESBURG: Three African countries have been chosen to test the world's first malaria vaccine, the World Health Organization announced Monday....
New vending machine at US varsity offers morning after pills Ruby Khatun Khatun26 April 2017 9:20 AM ISTLos Angeles, Apr 24: In a first, a vending machine designed by a student of Indian origin, that dispenses the morning after pill, has been installed...
Government Prohibits Stent companies to withdraw stents for Next Six Months Ruby Khatun Khatun25 April 2017 3:12 PM ISTNew Delhi: In a bid to prevent Multinational Stent makers from removing their next generation stents from the Indian Market, the central government...
India to make available J&J's bedaquiline at 140 government hospitals Ruby Khatun Khatun25 April 2017 11:00 AM ISTMUMBAI: India's top tuberculosis fighter said the government will expand access to Johnson & Johnson's breakthrough TB drug this year, but health...
FIPB refers Gland Pharma proposal to CCEA for approval Ruby Khatun Khatun25 April 2017 10:53 AM ISTNEW DELHI: Inter-ministerial body FIPB has recommended the Rs 4,315-crore foreign investment proposal of Gland Pharma Limited to the Cabinet Committee...
Eli Lilly reports positive interim data on breast cancer combo drug Ruby Khatun Khatun25 April 2017 10:42 AM ISTEli Lilly and Co said the combination of its experimental breast cancer drug and a commonly used treatment met the main goal of a late-stage study in...
Sanofi files US antitrust lawsuit against Mylan over EpiPen Ruby Khatun Khatun25 April 2017 10:42 AM ISTNew Jersey: Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen...
After Abbott, two more Stent makers seek withdrawal of New Gen Stents Ruby Khatun Khatun24 April 2017 1:39 PM ISTMUMBAI: Soon after Abbott was seen seeking withdrawal of its withdraw two types of stents from the Indian market, reports are coming in that two more...
Bristol-Myers NASH drug reduces liver fat in midstage study Ruby Khatun Khatun24 April 2017 12:14 PM ISTBy Bill BerkrotBristol-Myers Squibb Co said its lead experimental drug for nonalcoholic steatohepatitis, or NASH, significantly reduced liver fat...
Becton Dickinson to acquire Bard for 24 billion Dollars Ruby Khatun Khatun24 April 2017 12:08 PM ISTBy Carl O'Donnell and Jonathan SpicerNEW YORK: U.S. medical equipment supplier Becton Dickinson and Co will acquire C R Bard Inc, in a $24 billion...
